Piperaquine clinical trials
How each study uses piperaquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the piperaquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 27 Oct 2011 · Eurartesim · EMEA/H/C/001199 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
94 studies that test it; most in 2010 (9)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 7 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 89
University of Oxford (9) · University of California, San Francisco (7) · London School of Hygiene and Tropical Medicine (7) · Liverpool School of Tropical Medicine (6) · Medicines for Malaria Venture (5) · National Institute for Medical Research, Tanzania (4) · Radboud University Medical Center (3) · sigma-tau i.f.r. S.p.A. (3)
Often tested with
Tested in the same studies.
Artenimol (83) · Fanasil, pyrimethamine drug combination (14) · Artemether, Lumefantrine Drug Combination (11) · Amodiaquine (9) · Chloroquine (6) · Artesunate (5) · Primaquine (4) · Artefenomel (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test piperaquine, phase 3 first.
- May 2027Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Phase 3 · Grant Dorsey, M.D, Ph.D.
- Nov 2027A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy AdultsPhase 1 · University of Oxford
Studies
Open first, then newest update. How each study uses piperaquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 94
- Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community TransmissionRecruitingPhase 4University of California, San FranciscoNCT07246525Written as dihydroartemisinin-piperaquineHow we know
- Focal Mass Drug Administration for the Prevention of Malaria in PregnancyRecruitingEarly Phase 1University of North Carolina, Chapel HillNCT07021430Written as Dihydroartemisinin PiperaquineHow we know
- A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy AdultsNot yet recruitingPhase 1University of OxfordNCT07470424Written as PiperaquineHow we know
- Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium VivaxNot yet recruitingNot applicableWalter Reed Army Institute of Research (WRAIR)NCT07533136Written as Dihydroartemisinin-piperaquine (DHA-PPQ)How we know
- Perennial Malaria Chemoprevention in the Malaria Vaccine EraNot yet recruitingPhase 4Stanford UniversityNCT07322068Written as Dihydroartemisinin PiperaquineHow we know
- Safety of Antimalarials in the FIRst trimEsterRecruitingPhase 3Liverpool School of Tropical MedicineNCT06962319Written as dihydroartemisinin-piperaquine (DP)How we know
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingPhase 3Malaria ConsortiumNCT05946642Written as Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)How we know
- IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe FloodingActive, not recruitingNot applicableUniversity of North Carolina, Chapel HillNCT06870344Written as Dihydroartemisinin piperaquineHow we know
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, MalawiCompletedPhase 4Liverpool School of Tropical MedicineNCT06083688Written as Dihydroartemisinin-PiperaquineHow we know
- The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination TherapyCompletedPhase 4Infectious Diseases Research Collaboration, UgandaNCT06347471Written as Dihydroartemisinin-PiperaquineHow we know
- Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Active, not recruitingPhase 3Grant Dorsey, M.D, Ph.D.NCT04978272Written as Dihydroartemisinin-piperaquine (DP)How we know
- Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of AntimalarialsActive, not recruitingPhase 2/3Johns Hopkins Bloomberg School of Public HealthNCT04009343Written as Dihydroartemisinin-piperaquineHow we know
- Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in UgandaCompletedPhase 3Grant Dorsey, M.D, Ph.D.NCT04336189Written as Dihydroartemisinin-piperaquine (DP)How we know
- In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in MozambiqueCompletedPhase 4Centro de Investigacao em Saude de ManhicaNCT05343312Written as DHPHow we know
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyActive, not recruitingPhase 3Menzies School of Health ResearchNCT05426434Written as Dihydroartemisinin-Piperaquine (DP)How we know
- Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaActive, not recruitingPhase 3PATHNCT06516042Written as Dihydroartemisinin-piperaquineHow we know
- Dihydroartemisinin-Piperaquine in the Context of Antiretroviral TherapyCompletedPhase 4University of California, San FranciscoNCT04487145Written as Dihydroartemisinin-piperaquineHow we know
- Boosting the Impact of SMC Through Simultaneous Screening and Treatment of RoommatesCompletedPhase 4Institut de Recherche en Sciences de la Sante, Burkina FasoNCT04816461Written as Dihydroartemisinin-PiperaquineHow we know
- Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in TanzaniaCompletedPhase 3National Institute for Medical Research, TanzaniaNCT03640403Written as Dihydroartemisinin-piperaquineHow we know
- Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaCompletedPhase 4National Institute for Medical Research, TanzaniaNCT04245033Written as Dihydroartemisinin-Piperaquine (DP)How we know
See all 94 studies that test piperaquine →
Given beside what is tested · 11 — piperaquine is usual care or a partner of the new treatment
- Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated MalariaNot yet recruitingPhase 4Curtin UniversityNCT07403643Written as Dihydroartemisinin-piperaquine (DHA-PPQ)How we know
- Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)CompletedPhase 2London School of Hygiene and Tropical MedicineNCT04609098Written as Dihydroartemisinin/PiperaquineHow we know
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownPhase 3London School of Hygiene and Tropical MedicineNCT04844905Written as Dihydroartemisinin-piperaquineHow we know
- Malaria Elimination Pilot Study in Military Forces in CambodiaStatus unknownPhase 4Armed Forces Research Institute of Medical Sciences, ThailandNCT02653898Written as DHA-PIPHow we know
- Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in CambodiaCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02612545Written as Dihydroartemisinin-piperaquine (DHA-PPQ)How we know
- Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to MosquitosTerminatedPhase 1Novartis PharmaceuticalsNCT02543086Written as Piperaquine PhosphateHow we know
- Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyCompletedPhase 2Liverpool School of Tropical MedicineNCT02511353Written as dihydroartemisinin-piperaquineHow we know
- Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic CarriersCompletedPhase 3London School of Hygiene and Tropical MedicineNCT01838902Written as DHA-PPQHow we know
- Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in MalawiStatus unknownPhase 3Kamuzu University of Health SciencesNCT02721420Written as dihydroartemisinin-piperaquineHow we know
- Safety and Tolerability of Low Dose PrimaquineCompletedPhase 4Malaria ConsortiumNCT02434952Written as Dihydroartemisinin piperaquine (DHA PP)How we know
- Phase2a Primaquine Dose Escalation StudyCompletedPhase 2University of California, San FranciscoNCT01743820Written as dihydroartemisinin-piperaquineHow we know
As the comparator · 7 — what is tested is compared with piperaquine
- Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West PapuaCompletedPhase 2Syamsudin Abdillah,Ph.D, Pharm DNCT06036030Written as PiperaquineHow we know
- Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedPhase 1HuLowNCT02614404Written as Dihydroartemisinin-piperaquineHow we know
- Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT04049916Written as Dihydroartemisinin/PiperaquineHow we know
- Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant ParasitesStatus unknownPhase 2Nurex S.r.l.NCT03697668Written as Dihydroartemisinin-piperaquineHow we know
- Safety, Tolerability, Pharmacokinetics and Efficacy of ARCOCompletedPhase 4Ifakara Health InstituteNCT01930331Written as dihydroartemisinin/piperaquine phosphateHow we know
- Phase 2 Efficacy Study of Primaquine and Methylene BlueCompletedPhase 2University of California, San FranciscoNCT02831023Written as Dihydroartemisinin-piperaquineHow we know
- Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:CompletedPhase 4Institut Pasteur, CambodiaNCT02118090Written as DHA-PPHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Codes
What other systems call piperaquine · ClinicalTrials.gg INT003036
- MeSH (NLM) C034759piperaquineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A0HV2Q956YPIPERAQUINEConfirmed FDA, NLM, Wikidata
- Wikidata Q7197338piperaquineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87634PiperaquineOne source FDA
- DrugBank DB13941One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C034759 | piperaquine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A0HV2Q956Y | PIPERAQUINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7197338 | piperaquine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87634 | Piperaquine | One source FDA |
| DrugBank | DB13941 | — | One source Wikidata |
Also registered as piperaquine monophosphate (UNII 5A17BAT3GK), piperaquine phosphate (UNII IHB5WLO51Q) and piperaquine phosphate tetrahydrate (UNII 854D7K8LXB).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.